Inrebic

Indicated For

myelofibrosis

About This Medication

# BMS Access Support Patient Guide: How to Get INREBIC (Fedratinib) at Low or No Cost ## About INREBIC (Fedratinib) INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF), a serious blood disorder. Bristol Myers Squibb, the manufacturer, offers financial assistance programs to help eligible patients access this medication affordably or at no cost. ## Who Qualifies for Assistance INREBIC assistance is available through two main programs: **BMS Access Support Co-Pay Assistance Program** — For patients with commercial insurance who have been prescribed INREBIC. This program helps reduce your out-of-pocket costs. **Bristol Myers Squibb Patient Assistance Foundation (BMSPAF)** — For uninsured or underinsured patients with limited financial resources. This independent charitable organization may provide medication at no cost to eligible patients. ## Income Eligibility While specific income thresholds are not publicly listed, eligibility is determined based on your household income, insurance status, and residency. The programs are designed to help patients who struggle to afford their medications. **General Guidelines:** - Individual patients and families with limited incomes may qualify - Patients without insurance or with high out-of-pocket costs are prioritized - Income limits may vary based on family size and state of residence For exact income thresholds applicable to your situation, contact BMS Access Support directly at **(800) 861-0048**. ## Insurance Requirements | Program | Insurance Status | Eligibility | |---------|------------------|-------------| | Co-Pay Assistance | Commercial Insurance | Eligible for co-pay support | | BMSPAF | Uninsured/Underinsured | Eligible for free or reduced medication | | Government Insurance | Medicare, Medicaid, TRICARE | Not eligible for BMS co-pay programs; may qualify for independent charitable foundation support | **Important Note:** If you have government insurance (Medicare, Medicaid, or TRICARE), you are not eligible for BMS co-pay assistance. However, BMS Access Support can provide information about independent charitable foundations that may help you. ## Co-Pay Assistance Benefits If you have commercial insurance and qualify for the co-pay assistance program, you may pay as little as **$10 per one-month supply** of INREBIC, subject to a maximum benefit of **$15,000 per calendar year** (excluding certain dispensing costs). ## Step-by-Step Application Process **Step 1: Gather Required Documents** - Current prescription for INREBIC from your doctor - Proof of income (recent tax return, pay stubs, or benefit statements) - Proof of residency (utility bill or lease agreement) - Proof of insurance (insurance card or documentation) **Step 2: Contact BMS Access Support** - Call **(800) 861-0048**, available 8 AM to 8 PM ET - Ask to speak with a Patient Access Specialist - Alternatively, visit the BMS Access Support website or ask your doctor for assistance **Step 3: Complete Your Application** - A Patient Access Specialist will guide you through the application process - Provide all requested documentation - Answer questions about your income, insurance, and medical history **Step 4: Enrollment and Benefits Review** - Once enrolled, BMS Access Support will review your insurance coverage - You'll receive a summary of benefits within approximately **24 hours** - The review will clarify whether INREBIC is covered, if prior authorization is needed, and your estimated out-of-pocket costs **Step 5: Prior Authorization and Appeals Support** - If your insurance requires prior authorization, BMS Access Support will assist with this process - If your claim is denied, they can help with appeals, including providing medical necessity letters and appeals templates ## Timeline and Medication Delivery **Processing Time:** While specific processing times vary, BMS Access Support typically provides benefits reviews within approximately 24 hours of enrollment. **Delivery Method:** Once approved, your INREBIC will be shipped directly to you or your physician's office, depending on your preference and insurance requirements. **First Refill:** Subsequent refills are managed by BMS Access Support to ensure you receive your medication on schedule. ## Annual Reauthorization Your assistance eligibility requires **annual reverification**. BMS Access Support will contact you to update your information and confirm continued eligibility. It's important to respond promptly to maintain uninterrupted access to your medication. ## What If Your Application Is Denied? If you are denied assistance through BMS Access Support: 1. **Ask why** — Request a detailed explanation of the denial reason 2. **Appeal** — BMS Access Support can help you appeal the decision 3. **Explore alternatives** — Ask about independent charitable foundations that may provide support, especially if you have government insurance 4. **Contact your doctor** — Your healthcare provider may have additional resources or alternative treatment options ## Alternative Assistance Options If you don't qualify for BMS programs, other resources may be available: - **Prescription Hope** — A national advocacy program that may help obtain INREBIC for eligible patients - **Independent Charitable Foundations** — BMS Access Support can provide information about foundations that assist patients with financial hardship - **Patient Advocacy Groups** — Organizations focused on myelofibrosis may offer additional resources and support ## Important Reminders - This program is available to **U.S. residents only** - You must have a valid prescription from your doctor - Eligibility is based on income, insurance status, and residency - BMS Access Support cannot guarantee assistance, but they work to help as many eligible patients as possible - Translation services are available in multiple languages — ask when you call ## Contact Information **BMS Access Support** - Phone: **(800) 861-0048** - Hours: 8 AM to 8 PM ET - Ask for a Patient Access Specialist **Bristol Myers Squibb Patient Assistance Foundation (BMSPAF)** - For uninsured or underinsured patients - Contact through BMS Access Support for referral ## Disclaimer This guide provides general information about BMS Access Support programs for INREBIC. Eligibility criteria, benefits, and program details are subject to change. For the most current and accurate information, contact BMS Access Support directly. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement or assistance approval.

Program information last verified: March 30, 2026